Abstract: Cenchrus ciliaris L. as an anticancer agent was obtained by separately extracting the aerial parts of the plant and the root part of the plants. Extractions were performed first in ethanol, and then a portion successively in water, chloroform, and aqueous butanol. All extracts were tested for cytotoxicity against six cancer cell lines. Generally, the root extracts exhibited greater cytotoxicity than the aerial extracts. The highest anticancer effects for both aerial and root extracts were shown against hepatocellular cancer, colorectal cancer, and lung cancer, compared to the other cell lines tested. The chloroform extracts showed greater anticancer effects, both for aerial and root extracts.

Abstract: The gastroprotective extracts of S. oleraceus L. are ethanol extracts (including the initial ethanol extract and serial extractions of the marc in ethanol), which are concentrated at low temperature to obtain a gummy residue that is dissolved in water. Lipoidal compounds are removed from aqueous extracts by filtration, and serial extracts proceeding from the aqueous extracts using chloroform to obtain low polarity phenolic compounds and n-butanol to obtain high polarity compounds and any remaining compounds. These extracts may be used to treat conditions of the stomach and colon including preventing peptic ulcers and treating ulcerative colitis.

Abstract: The anticancer extracts of Alpinia officinarum Hance are produced by percolation extraction of dried Alpinia officinarum Hance rhizomes in 95% ethanol. The extracts may then be concentrated, suspended in water, filtered, and lyophilized. The resulting anticancer extracts may be used to kill a variety of cancer cells, including lung cancer, colorectal cancer, colon cancer, cervical cancer, and prostate cancer.

Abstract: Anti-ulcerative colitis compounds include quinazoline derivatives having the following structural formula: wherein R is H, OH, or OCH3, R1 is OH or OCH3, and R2 is OCH3 or a pharmaceutically acceptable salt thereof.

Abstract: Anti-ulcerative colitis compounds include quinazoline derivatives having the following structural formula: wherein R is H, OH, or OCH3, R1 is OH or OCH3, and R2 is OCH3, or a pharmaceutically acceptable salt thereof.

Abstract: A method for treating candidiasis includes administering to a human or animal subject in need thereof, a therapeutically effective amount of an anti-candidiasis compound. The anti-candidiasis compound can include 3?-diglucoside-5, 12-28-oic acid. The anti-candidiasis can be isolated from an extract of Petriella setifera or other Petriella species.

Abstract: An amino substituted acetamide derivative can include a compound having the following general formula: wherein R represents (4-Cyano-4-phenyl)piperidinyl hydrochloride, (4-Hydroxy-4-phenyl)piperidine, (4-chlorophenyl)piperidine hydrochloride, 4-Piperidinopiperidine, 4-(Methoxyphenyl)piperidine, 1-(2,3-xylyl)piperazine monohydrochloride, 4-Aminoquinaldine or anthranilic acid, or a pharmaceutically acceptable salt thereof.